Dr. Maria De La Pena, M.D
What this data tells you about Dr. De La Pena
Dr. Maria De La Pena is a student in an organized health care education/training program specialist in Fort Lauderdale, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. De La Pena performed 7,207 Medicare services across 2,082 unique beneficiaries.
Between the years covered by Open Payments, Dr. De La Pena received a total of $18,671 from 47 pharmaceutical and/or device companies across 488 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. De La Pena is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 114029 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) | 1,199 | $0 | $1 |
| Steroid injection (triamcinolone) | 1,155 | $1 | $9 |
| Hospital follow-up visit, high complexity | 1,110 | $97 | $920 |
| Hospital follow-up visit, moderate complexity | 580 | $64 | $643 |
| Office visit, established patient (30-39 min) | 521 | $98 | $913 |
| Office visit, established patient (20-29 min) | 433 | $71 | $644 |
| Drug screening test | 338 | $61 | $249 |
| Critical care, first 30-74 min | 320 | $174 | $2,008 |
| Initial hospital admission, high complexity | 292 | $136 | $1,414 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 164 | $153 | $626 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 135 | $242 | $988 |
| Injection, ketorolac tromethamine, per 15 mg | 97 | $0 | $4 |
| Initial hospital admission, moderate complexity | 96 | $104 | $968 |
| Fluoroscopic guidance for needle placement | 87 | $94 | $807 |
| Joint injection, major joint | 72 | $62 | $528 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 57 | $27 | $238 |
| Injection of substance into lower spine canal using imaging guidance | 51 | $210 | $1,874 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 46 | $213 | $1,818 |
| Office visit, established patient, complex (40-54 min) | 40 | $142 | $1,280 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 39 | $195 | $795 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 38 | $157 | $1,346 |
| Evaluation of neuropsychological test, first hour | 34 | $105 | $908 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 31 | $345 | $2,993 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 30 | $213 | $1,731 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 30 | $205 | $1,650 |
| Destruction of nerves supplying joint between spine and pelvis using imaging guidance | 30 | $378 | $3,377 |
| New patient office visit, complex (60-74 min) | 30 | $174 | $1,587 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 24 | $341 | $3,024 |
| New patient office visit (45-59 min) | 24 | $120 | $1,123 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 20 | $113 | $880 |
| Testing of autonomic nervous system function and heart rate response to deep breathing | 20 | $67 | $601 |
| Testing of autonomic (sympathetic) nervous system function | 20 | $94 | $843 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 16 | $111 | $852 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 15 | $91 | $795 |
| Injection of substance into middle or upper spine canal using imaging guidance | 13 | $213 | $1,906 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for student in an organized health care education/training program in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. De La Pena is a clinical cardiology specialist, with above-average Medicare volume (top 3% in FL), with low-engagement industry engagement in the top 2% of FL peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. De La Pena experienced with dexamethasone injection (steroid)?
Does Dr. De La Pena receive payments from pharmaceutical companies?
How do Dr. De La Pena's costs compare to other student in an organized health care education/training programs in Fort Lauderdale?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology